Congenica showcased in Genomics Spotlight 2024 Report
Congenica Named Best Genomic Data Analysis Software Company 2024 by GHP
Congenica selected for final phase of Instand-NGS4P
Webinar: From Research to Transforming Patients' Lives
Congenica founders celebrate a decade of innovation
Professor Matthew Hurles discusses the Deciphering Developmental Disorders study
Congenica announces Early Access Program for its novel Precision Oncology Solution
Who we are
We are a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale.
We drive Precision Medicine and help reduce the burden on healthcare systems by delivering rapid and automated analysis and interpretation solutions to healthcare providers worldwide.
Our Technology
Congenica was founded based on pioneering work at the Wellcome Trust Sanger Institute and the UK NHS. Our products combine state-of-the-art technology, market-leading automation and Artificial Intelligence to enable our uniquely differentiated platform to be employed in all areas of human disease where genomic information is key to unlock actionable insights.
Automated platform
Full automation with powerful APIs and ML to reduce burden on specialist staff, maximise case throughput, accelerate interpretation and streamline reporting
Commitment to quality
Certified, accurate and secure analysis platform to support genomic analysis with the highest degree of confidence in the outcome.
Ultimate flexibility
From gene panels to whole genomes, SaaS or on premise, we offer ultimate flexibility to support all customer needs
Easy-to-integrate solution
APIs designed to be compatible with existing workflow solutions, LIMS systems and EHRs for optimised operational efficiency
Our Products and Services
Our products and services are consolidated on one single scalable, automated analysis platform that encompasses inherited disease and cancer, pharma insights and pathogen surveillance. Our platform is uniquely placed to support our customers to make ubiquitous use of complex data in routine clinical care.
At Congenica, we understand how to transform complex genetic data into actionable insights to drive precision medicine at scale
Rob Denison CEO Congenica